ÂÜÀòÂÒÂ×

Thomas Südhof, MD, is the Avram Goldstein Professor in Stanford University School of Medicine and serves as a professor of Molecular & Cellular Physiology and Neurosurgery, and, by courtesy, of Psychiatry and Neurology. In addition, he is an investigator of the Howard Hughes Medical Institute and has been an advisor at Catalio Venture Partners since 2019. Previously Dr. Südhof spent 25 years at the University of Texas, Southwestern, where he acted as Chairman of the Department of Neuroscience. Most of his research at that time focused on the mechanisms of synaptic information transmission which have pharmacological consequences for the treatment of neurodegenerative and neuropsychiatric diseases. He is co-founder and a member of numerous scientific committees of companies and biotechs based in the United States. Dr. Südhof won the Nobel Prize in Physiology or Medicine (shared with James Rothman and Randy Shekman) in 2013, the Albert Lasker Medical Basic Research Award (shared with Richard Scheller), as well as the Bernhard Katz Award of the Biophysical Society (shared with Reinhard Jahn). He holds a Medical Degree from the University of Göttingen Medical School (Germany) and a Doctoral Degree from the Max Planck Institut/University of Göttingen (Germany).